Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan L Shaw

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Virology|March 15, 2013
Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virusJudith G Alamares-Sapuay, Luis Martinez-Gil, Silke Stertz, et al.
Journal of Virology|August 27, 2010
Novel Nipah virus immune-antagonism strategy revealed by experimental and computational studyJeremy Seto, Liang Qiao, Carolin A Guenzel, et al.
Msphere|November 16, 2018
Nucleolar Relocalization of RBM14 by Influenza A Virus NS1 ProteinGrant Beyleveld, Daniel J Chin, Elena Moreno Del Olmo, et al.
Journal of Virology|November 8, 2013
Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitorEmilio Ortiz-Riaño, Nhi Ngo, Stefanie Devito, et al.
Plos Pathogens|May 12, 2012
A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferonMila Brum Ortigoza, Oliver Dibben, Jad Maamary, et al.
Journal of Virology|December 28, 2002
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteinsMan-Seong Park, Megan L Shaw, Jorge Muñoz-Jordan, et al.
Journal of Virology|May 16, 2006
Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulationSt Patrick Reid, Lawrence W Leung, Amy L Hartman, et al.
ACS Infectious Diseases|December 23, 2017
Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral NucleoproteinKris M White, Pablo Abreu, Hui Wang, et al.
Viruses|July 29, 2023
LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in HamstersWarren R J de Moor, Anna-Lise Williamson, Georgia Schäfer, et al.
Scientific Reports|May 16, 2018
Author Correction: SMARCA2-regulated host cell factors are required for MxA restriction of influenza A virusesDominik Dornfeld, Alexandra H Dudek, Thibaut Vausselin, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Virology|March 15, 2013
Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virusJudith G Alamares-Sapuay, Luis Martinez-Gil, Silke Stertz, et al.
Journal of Virology|August 27, 2010
Novel Nipah virus immune-antagonism strategy revealed by experimental and computational studyJeremy Seto, Liang Qiao, Carolin A Guenzel, et al.
Msphere|November 16, 2018
Nucleolar Relocalization of RBM14 by Influenza A Virus NS1 ProteinGrant Beyleveld, Daniel J Chin, Elena Moreno Del Olmo, et al.
Journal of Virology|November 8, 2013
Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitorEmilio Ortiz-Riaño, Nhi Ngo, Stefanie Devito, et al.
Plos Pathogens|May 12, 2012
A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferonMila Brum Ortigoza, Oliver Dibben, Jad Maamary, et al.
Journal of Virology|December 28, 2002
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteinsMan-Seong Park, Megan L Shaw, Jorge Muñoz-Jordan, et al.
Journal of Virology|May 16, 2006
Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulationSt Patrick Reid, Lawrence W Leung, Amy L Hartman, et al.
ACS Infectious Diseases|December 23, 2017
Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral NucleoproteinKris M White, Pablo Abreu, Hui Wang, et al.
Viruses|July 29, 2023
LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in HamstersWarren R J de Moor, Anna-Lise Williamson, Georgia Schäfer, et al.
Scientific Reports|May 16, 2018
Author Correction: SMARCA2-regulated host cell factors are required for MxA restriction of influenza A virusesDominik Dornfeld, Alexandra H Dudek, Thibaut Vausselin, et al.
Pageof 4